The United States lost more than 22,000 lives to Covid-19 for the week ended Jan. 10, setting a record for the second week in a row, as new cases also hit a weekly high.
California compelled much of the state to close shop and stay at home on Dec. 7, when some of the harshest coronavirus restrictions in the United States came into effect one day after the state set a record with more than 30,000 new Covid-19 cases.
The United States reported a record increase in coronavirus cases for a fourth consecutive day with at least 131,420 new infections, bringing the country’s total caseload to about 9.91 million, according to a Reuters tally.
Seven U.S. states reported record one-day increases in Covid-19 cases so far in September even as the average daily number of new infections is falling nationally.
The United States reported more than 59,000 new COVID-19 cases on Wednesday, the biggest increase ever reported by a country in a single day, according to a Reuters tally.
The United States saw a 27 percent increase in new cases of COVID-19 in the week ended July 5 compared to the previous seven days, with 24 states reporting positivity test rates above the level that the World Health Organization flagged as concerning.
A U.S. district court ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc.’s blockbuster multiple sclerosis drug Tecfidera, sending Biogen’s shares down nearly 6 percent.
Better-than-expected social distancing practices have led an influential research model to lower the projected U.S. coronavirus death toll by 12 percent, while predicting some states may be able to safely begin easing restrictions as early as May 4.
Five U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.
Drug distributor McKesson Corp. agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold the company responsible for contributing to the opioid epidemic, the state’s attorney general said.